[HTML][HTML] COVID-19 a triggering factor of autoimmune and multi-inflammatory diseases

EK Sher, A Ćosović, A Džidić-Krivić, EK Farhat, E Pinjić… - Life sciences, 2023 - Elsevier
SARS-Cov-2 virus has attracted a lot of attention globally, due to the autoimmune and
inflammatory processes that were observed during the development of Covid-19 disease …

What do we need to know about musculoskeletal manifestations of COVID-19?: a systematic review

RE Pires, IGN Reis, GS Waldolato, DD Pires… - JBJS …, 2022 - journals.lww.com
What Do We Need to Know About Musculoskeletal Manifestations... : JBJS Reviews What Do
We Need to Know About Musculoskeletal Manifestations of COVID-19?: A Systematic Review …

COVID‐19‐induced autoimmune thyroiditis: Exploring molecular mechanisms

B Mohammadi, K Dua, M Saghafi… - Journal of medical …, 2023 - Wiley Online Library
Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) damages multiple
organs, including the thyroid, by direct invasion and cell entry via angiotensin‐converting …

COVID-19 heart lesions in children: clinical, diagnostic and immunological changes

E Vasichkina, D Alekseeva, I Kudryavtsev… - International Journal of …, 2023 - mdpi.com
In the beginning of COVID-19, the proportion of confirmed cases in the pediatric population
was relatively small and there was an opinion that children often had a mild or asymptomatic …

IFI44 is an immune evasion biomarker for SARS-CoV-2 and Staphylococcus aureus infection in patients with RA

Q Zheng, D Wang, R Lin, Q Lv, W Wang - Frontiers in immunology, 2022 - frontiersin.org
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a
global pandemic of severe coronavirus disease 2019 (COVID-19). Staphylococcus aureus is …

National trends in rheumatoid arthritis and osteoarthritis prevalence in South Korea, 1998–2021

J Park, M Lee, H Lee, HJ Kim, R Kwon, H Yang… - Scientific reports, 2023 - nature.com
Studies on the trends in the prevalence of rheumatoid arthritis (RA) and osteoarthritis (OA)
are limited, particularly during the COVID-19 pandemic. This study aimed to analyze the …

Exploring the mechanism of Celastrol in the treatment of rheumatoid arthritis based on systems pharmacology and multi-omics

L Zeng, G Yu, K Yang, Q He, W Hao, W Xiang… - Scientific Reports, 2024 - nature.com
To explore the molecular network mechanism of Celastrol in the treatment of rheumatoid
arthritis (RA) based on a novel strategy (integrated systems pharmacology, proteomics …

TREC/KREC levels and T and B lymphocyte subpopulations in COVID-19 patients at different stages of the disease

AA Savchenko, E Tikhonova, I Kudryavtsev, D Kudlay… - Viruses, 2022 - mdpi.com
Background: T and B cell-mediated immunity can be assessed using T cell receptor excision
circle (TREC) and Kappa-deleting recombination excision circle (KREC) analysis …

Development of nanozymes for promising alleviation of COVID-19-associated arthritis

D Li, B Zhao, P Zhuang, X Mei - Biomaterials Science, 2023 - pubs.rsc.org
The COVID-19 pandemic caused by SARS-CoV-2 has been identified as a culprit in the
development of a variety of disorders, including arthritis. Although the emergence of arthritis …

Disentangling the common genetic architecture and causality of rheumatoid arthritis and systemic lupus erythematosus with COVID‐19 outcomes: Genome‐wide …

M Yao, X Huang, Y Guo, JV Zhao… - Journal of Medical …, 2023 - Wiley Online Library
Abstract Coronavirus Disease (COVID‐19) may cause a dysregulation of the immune
system and has complex relationships with multiple autoimmune diseases, including …